Research

New Cancer Drug Makes Commonly Prescribed Chemo Drug More Effective When Given Together


Computer tomography
By Donna Ramirez | June 13, 2017

Researchers have found a way to increase the effectiveness of a widely used cancer drug while decreasing the risk of heart-damaging side effects, according to a new study by researchers from The University of Texas Medical Branch at Galveston and Texas Tech University Health Sciences Center. The findings are currently available in the Journal Scientific Reports Nature publishing group.

UTMB professor Satish Srivastava said that combining a newly-developed drug with a drug used to fight numerous kinds of cancers makes it better suited as a colon cancer treatment. The widely-used drug, doxorubicin, is effective in fighting cancer but can be toxic to the heart when higher doses are needed.

The research, Srivastava said, shows that using aldose reductase inhibitors, an enzyme, when used with doxorubicin, reduces the toxins that can damage the heart.

The researchers have shown earlier that exposure to cancer-causing agents like pollutants triggers oxidative stress, which is a driving source of cancer tissue growth. The oxidative signals are also involved in growing the new blood vessels needed by the cancer tissues. An effort to decrease the oxidative signals is one of the reasons for the popularity of antioxidant-containing foods, beverages, skin care products and vitamins.

“We’ve shown that oxidative signals can be blocked by aldose reductase, or AR, inhibitors,” said lead author Srivastava, who is a professor in UTMB’s departments of biochemistry and molecular biology as well as ophthalmology and visual sciences. “If we could prevent development of the new blood vessels in the cancer tissue driven by these signals, tumor growth and metastasis can be slowed down or prevented.”

The researchers have been using an AR inhibitor called fidarestat to learn how well it prevents growth and metastasis of cancer. The drug has completed Phase II clinical trials in the U.S. and Phase III in Japan for preventing diabetic neuropathy and was found to have no major side effects.

Doxorubicin is commonly prescribed to fight several types of cancers including breast and lung cancers. It is also very cost effective, compared to other cancer drugs. However, colon cancers become resistant to this drug so a higher dosage must be used for it to be effective. The trouble with this is that at higher dosages, it can be toxic to the heart.

“In the study, using human colon cancer cell lines, we showed that the growth of cancer cells can be largely prevented using a combination of both drugs in a petri dish as well as in mouse models,” said Srivastava. “Since doxorubicin is one of the cheapest drugs that is effective against many types of cancer but rarely used in colon cancer, the combination therapy could be highly effective in combating colon cancer while drastically lowering risk of cardiotoxic side effects.”

Srivastava said that since the FDA-approved fidarestat is available through a company in Japan, his eventual goal is to use a combination of fidarestat and doxorubicin to combat various forms of cancer including colon cancer with the hope that combination therapy will require less doxorubicin, which will reduce the potential for toxicity.

Other authors include UTMB’s Himangshu Sonowal, Pabitra Pal, Jian-Jun Wen and Kota Ramana as well as Sanjay Awasthi from Texas Tech University Health Sciences Center. The study was supported by the National Institutes of Health.

Tags | Research



Social Posts

profile_image

Houston Methodist

@MethodistHosp

@VillageVikings It was our pleasure. Thanks for sharing the photo. ^SF

9 hours ago
profile_image

Houston Methodist

@MethodistHosp

@m_evangelo Thanks for sharing ^SF

9 hours ago
profile_image

Houston Methodist

@MethodistHosp

@WolframJoy Thanks for sharing ^SF

9 hours ago
profile_image

Memorial Hermann

@memorialhermann

Here’s a list of products a dermatologist recommends for women in their 20s, 30s, 40s and beyond: https://t.co/MkaskS4yfE. https://t.co/h7vvvMR4ky

10 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Tips for navigating a new #cancer diagnosis: https://t.co/FIMIqkN6wq #endcancer https://t.co/oI7VmejX4T

11 hours ago
profile_image

UTHealth

@UTHealth

In an interview with @KPRCradio Fifty+ host Doug Pike, Dr. Holly Holmes of @McGovernMed addressed the challenges faced by seniors taking multiple medications: https://t.co/yoUunBzKyx

11 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

@NicFlenn Great news! We are sending you our best wishes.

11 hours ago
profile_image

UTHealth

@UTHealth

RT @MDA_UTHGrad: Check out the finalists for the 2018 GSBS Student Research Day Poster Session: https://t.co/NGqkBOUwfj. Remember, #GSBSsrd…

11 hours ago
profile_image

UTHealth

@UTHealth

RT @CLI_UTHealth: Our 8th Annual Institute is off to a great start and we are having a blast! Thanks to all of our presenters, attendees an…

11 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

#Lymphoma caregiver, wife Kim Cunnea on MD Anderson: “There are lots of opportunities to be healed in lots of ways and tons of opportunities for caregivers to get the support they need.” #endcancer https://t.co/9GHyX2k1ot

12 hours ago
profile_image

BCMHouston

@bcmhouston

Dr. Sophia Banu has been around the globe helping people during some of their most challenging times of their lives. https://t.co/q3k0AQLKOK #WorldRefugeeDay

12 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

VA releases national suicide data report: Analysis part of VA’s comprehensive examination of more than 55 million death records https://t.co/tEvt9gnVFh via #VAntagePoint

12 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Stand Down event provides supplies and services to homeless Veterans in Michigan https://t.co/tpRnDmZ9Zm via @wzzm13

13 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Today’s #VeteranOfTheDay is @USArmy Veteran Parrish Andre Fitts. https://t.co/TKAGbhyNrw

14 hours ago
profile_image

Memorial Hermann

@memorialhermann

Huey, who has diabetes, nearly lost his leg after developing an infection in his toe. But thanks to an advanced wound care treatment he was saved from an amputation. Read his story: https://t.co/Y7UtgUaUai. https://t.co/NzX6KZ73DD

15 hours ago